LRMR / Larimar Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Larimar Therapeutics, Inc.
US ˙ NasdaqGM ˙ US5171251003

Utestående aktier 85,590,392 shares
Insideraktier22 896 118 shares
Insynsägande26,75 %
Totalt antal insynspersoner47
Insider Sentiment Score

Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.

Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.

Uppdateringsfrekvens: Dagligen

Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.

Office Sentiment Score

Officersentiment Score hittar företag som köps av Corporate Officers.

Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.

Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.

Uppdateringsfrekvens: Dagligen

Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.

Viktiga insidernyckeltal

Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.

Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).

Nettoantalet insiders som köper (rankning)

1 ( )

327 out of 11275

Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).

Procent av flytande köpta av insiders (ranking)

21.731 %( )

5 out of 11219

Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.

Insiderhandelsdiagram

Larimar Therapeutics, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.

Insiderlista och lönsamhetsstatistik

Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.

See our leaderboard of most profitable insider traders.

Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
Patricia L Allen Chief Financial Officer - [O] 19 793 19 793
Atlas Venture Associates VII, Inc. 10% Owner - [10%] 11 11
Atlas Venture Associates VII, L.P. 10% Owner - [10%] 11 11
Atlas Venture Fund VII L P 10% Owner - [10%] 11 11
Carole Ben-maimon President and CEO, Director - [D] [O] 387 208 387 208
Peter Barrett Director, 10% Owner - [D] [10%] 4 643 327 4 643 327
Bruce Booth Director, 10% Owner - [D] [10%] 4 638 028 4 638 028
Chondrial Therapeutics Holdings, Llc 10% Owner - [10%] 8 8
Michael Celano Chief Financial Officer - [O] 178 181 178 181
Russell Clayton Chief Medical Officer - [O] 45 806 45 806
Management Co Deerfield 10% Owner - [10%] 8 300 11 529 111
Deerfield Partners, L.p. 10% Owner - [10%] 5 555 554 11 529 111
Thomas O Daniel Director - [D] 19 452 19 452
Deerfield Healthcare Innovations Fund, L.P. Director, 10% Owner - [D] [10%] 1 943 420 11 529 111
Deerfield International Master Fund, L.P. 10% Owner - [10%] 1 151 802 1 151 802
Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
Deerfield Mgmt HIF, L.P. Director, 10% Owner - [D] [10%] 1 943 420 11 529 111
Deerfield Mgmt III, L.P. Director, 10% Owner - [D] [10%] 1 943 420 11 529 111
Deerfield Mgmt IV, L.P. Director, 10% Owner - [D] [10%] 1 943 420 11 529 111
Deerfield Mgmt L.P. 10% Owner - [10%] 1 151 802 11 529 111
Deerfield Private Design Fund III, L.P. Director, 10% Owner - [D] [10%] 1 943 420 11 529 111
Deerfield Private Design Fund IV, L.P. Director, 10% Owner - [D] [10%] 1 943 420 11 529 111
Deerfield Special Situations Fund, L.P. 10% Owner - [10%] 1 151 802 1 151 802
Wendy Everett 27 000
James E Flynn Director, 10% Owner - [D] [10%] 11 529 111 11 529 111
Goldberg Avi Y. Director - [D] 53 734 53 734
Thomas Edward Hamilton Director - [D] 724 231 724 231
Hatfield Jeffrey S. 525 000
Frances K Heller Director - [D] 47 961 47 961
Hughes Thomas E. See Remarks, Director - [D] [O] 125 247 125 247
Dennis D Kim Chief Medical Officer - [O] 21 443 21 443
John L Lamattina Director - [D] 31 376 31 376
Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
Jonathan S Leff 8 300
Mark J Levin 10% Owner - [10%] 0 0
Patrick Loustau 56 500
Cameron Geoffrey McDonough Director - [D] 0 0
Brian McVeigh 125 000
Robert J Perez Director - [D] 5 322 5 322
Kevin P Starr Director - [D] 370 323 370 323
Alicia Secor Chief Commercial Officer - [O] 0 0
Gopi Shankar Chief Development Officer - [O] 50 806 50 806
Priya Singhal 375 000
Robert I Tepper 10% Owner - [10%] 0 0
Third Rock Ventures Lp 10% Owner - [10%] 0 0
Frank E Thomas Director - [D] 2 000 2 000
Trv Gp, Llc 10% Owner - [10%] 0 0
Third Rock Ventures GP, L.P. 10% Owner - [10%] 0 0
Joseph Truitt Director - [D] 2 750 2 750

Report errors via our new Insider Auditing Tool

Track Records av insiderköp - Kortsiktig vinstanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i LRMR / Larimar Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Max
Pris vid
Max
Maximal
vinst ($)
Maximal avkastning (%)
2025-07-31 Flynn James E 2 599 932 3,2000 2 599 932 3,2000 8 319 782 49 4.2800 2 807 927 33,75
2025-07-31 Flynn James E 3 387 539 3,2000 3 387 539 3,2000 10 840 125
2025-07-31 Flynn James E 3 387 529 3,2000 3 387 529 3,2000 10 840 093
2024-02-16 Flynn James E 1 430 205 8,7400 1 430 205 8,7400 12 499 992
2024-02-16 Flynn James E 1 430 206 8,7400 1 430 206 8,7400 12 500 000
2024-02-16 Flynn James E 1 430 206 8,7400 1 430 206 8,7400 12 500 000
2024-02-16 Hamilton Thomas Edward 57 208 8,7400 57 208 8,7400 499 998
2024-02-14 THOMAS FRANK E 2 000 11,0000 2 000 11,0000 22 000
2023-12-07 Shankar Gopi 5 000 3,7323 5 000 3,7323 18 662

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

LRMR / Larimar Therapeutics, Inc. Insider Trades
Track Records av insiderförsäljning - Kortsiktig förlustanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i LRMR / Larimar Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Min
Pris vid
Min
Maximal förlust
undvikits ($)
Maximal förlust
undvikits ($)
2016-07-20 Flynn James E 901 430 3,3118 901 430 3,3118 2 985 356 8
2016-07-20 Flynn James E 246 439 3,3118 246 439 3,3118 816 157
2016-07-20 Flynn James E 193 630 3,3118 193 630 3,3118 641 264
2015-09-24 STARR KEVIN P 61 630 44,1000 61 630 44,1000 2 717 883
2015-09-24 STARR KEVIN P 74 949 43,7300 74 949 43,7300 3 277 520
2015-09-17 KIM DENNIS D 9 142 40,0000 9 142 40,0000 365 680
2015-09-15 KIM DENNIS D 30 265 40,0000 30 265 40,0000 1 210 600
2015-09-14 KIM DENNIS D 593 40,0000 593 40,0000 23 720

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

LRMR / Larimar Therapeutics, Inc. Insider Trades
Transaktionshistorik

Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.

Fil
datum
Handel
datum
Schema Insider Ticker Värdepappertitel Kod 10b5-1 Direkta Utövningspris Enhet
pris
Enheter
ändrad
Värde
ändrad (1K)
Kvarvarande
Optioner
Kvarvarande
Aktier
2025-08-04 2025-07-31 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. LRMR Common Stock P - Purchase I 3,2000 2 599 932 8 320 7 321 129
2025-08-04 2025-07-31 4 Flynn James E Through Deerfield Private Design Fund IV, L.P. LRMR Common Stock P - Purchase I 3,2000 3 387 539 10 840 9 538 945
2025-08-04 2025-07-31 4 Flynn James E Through Deerfield Private Design Fund III, L.P. LRMR Common Stock P - Purchase I 3,2000 3 387 529 10 840 9 538 918
2025-01-24 2025-01-22 4 Clayton Russell LRMR Common Stock A - Award D 23 306 45 806
2025-01-24 2025-01-22 4 Shankar Gopi LRMR Common Stock A - Award D 23 306 50 806
2025-01-24 2025-01-22 4 BEN-MAIMON CAROLE LRMR Common Stock A - Award D 91 000 387 208
2025-01-24 2025-01-22 4 Celano Michael LRMR Common Stock A - Award D 34 185 178 181
2024-05-31 2024-02-16 4 Hamilton Thomas Edward LRMR Common Stock P - Purchase D 8,7400 57 208 500 564 798
2024-02-16 2024-02-16 4 Flynn James E Through Deerfield Partners, L.P. LRMR Common Stock P - Purchase I 8,7400 1 430 205 12 500 4 207 982
2024-02-16 2024-02-16 4 Flynn James E Through Deerfield Private Design Fund III, L.P. LRMR Common Stock P - Purchase I 8,7400 1 430 206 12 500 6 151 406
2024-02-16 2024-02-16 4 Flynn James E Through Deerfield Private Design Fund IV, L.P. LRMR Common Stock P - Purchase I 8,7400 1 430 206 12 500 6 151 406
2024-02-15 2024-02-14 4 THOMAS FRANK E LRMR Common Stock P - Purchase D 11,0000 2 000 22 2 000
2024-01-19 2024-01-17 4 Shankar Gopi LRMR Common Stock A - Award D 22 500 27 500
2024-01-19 2024-01-17 4 Celano Michael LRMR Common Stock A - Award D 31 250 143 996
2024-01-19 2024-01-17 4 BEN-MAIMON CAROLE LRMR Common Stock A - Award D 66 125 332 954
2024-01-19 2024-01-17 4 Clayton Russell LRMR Common Stock A - Award D 22 500 22 500
2023-12-08 2023-12-07 4 Shankar Gopi LRMR Common Stock P - Purchase D 3,7323 5 000 19 5 000
2023-05-18 2023-05-17 4 BEN-MAIMON CAROLE LRMR Common Stock P - Purchase D 3,7050 5 000 19 266 829
2023-05-18 2023-05-17 4 Celano Michael LRMR Common Stock P - Purchase D 3,7263 5 000 19 112 746
2023-05-18 2023-05-17 4 Truitt Joseph LRMR Common Stock P - Purchase D 3,7300 2 750 10 2 750
2023-02-02 2023-01-31 4 Celano Michael LRMR Common Stock A - Award D 76 000 107 746
2023-02-02 2023-01-31 4 BEN-MAIMON CAROLE LRMR Common Stock A - Award D 205 000 261 829
2022-09-20 3 Deerfield Mgmt L.P. LRMR Common Stock D 2 777 777
2022-09-20 2022-09-16 4 Flynn James E Through Deerfield Partners, L.P. LRMR Common Stock P - Purchase I 3,1500 2 777 777 8 750 2 777 777
2022-09-20 2022-09-16 4 Flynn James E Through Deerfield Private Design Fund IV, L.P. LRMR Common Stock P - Purchase I 3,1500 2 777 777 8 750 2 777 777
2022-09-20 2022-09-16 4 Flynn James E Through Deerfield Private Design Fund III, L.P. LRMR Common Stock P - Purchase I 3,1500 2 777 777 8 750 2 777 777
2022-09-20 2022-09-16 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. LRMR Common Stock P - Purchase I 3,1500 2 777 777 8 750 2 777 777
2022-09-20 2022-09-16 4 Hamilton Thomas Edward LRMR Common Stock P - Purchase D 3,1500 317 460 1 000 507 590
2022-09-19 2022-09-16 4 BEN-MAIMON CAROLE LRMR Common Stock P - Purchase D 3,1500 31 746 100 56 829
2022-09-19 2022-09-16 4 Celano Michael LRMR Common Stock P - Purchase D 3,1500 31 746 100 31 746
2022-05-12 2022-05-10 4 Truitt Joseph LRMR Stock Option (Right to Buy) A - Award D 2,92 8 300 8 300
2022-05-12 2022-05-10 4 LEFF JONATHAN S LRMR Stock Option (Right to Buy) A - Award D 2,92 8 300 8 300
2022-05-12 2022-05-10 4 Celano Michael LRMR Stock Option (Right to Buy) A - Award D 2,92 20 000 20 000
2022-05-12 2022-05-10 4 BEN-MAIMON CAROLE LRMR Stock Option (Right to Buy) A - Award D 2,92 40 000 40 000
2022-05-12 2022-05-10 4 THOMAS FRANK E LRMR Stock Option (Right to Buy) A - Award D 2,92 8 300 8 300
2022-05-12 2022-05-10 4 Barrett Peter LRMR Stock Option (Right to Buy) A - Award D 2,92 8 300 8 300
2022-05-12 2022-05-10 4 Hamilton Thomas Edward LRMR Stock Option (Right to Buy) A - Award D 2,92 8 300 8 300
2022-05-11 2022-05-10 4 Flynn James E Through Deerfield Management Company, L.P. LRMR Stock Option (Right to Buy) A - Award I 2,92 8 300 8 300
2022-01-20 2022-01-18 4 Celano Michael LRMR Stock Option (Right to Buy) A - Award D 8,75 80 000 80 000
2022-01-20 2022-01-18 4 BEN-MAIMON CAROLE LRMR Stock Option (Right to Buy) A - Award D 8,75 182 000 182 000
2021-07-02 2021-06-30 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. LRMR Common Stock P - Purchase I 8,7500 228 570 2 000 1 943 420
2021-07-02 2021-06-30 4 Flynn James E Through Deerfield Private Design Fund IV, L.P. LRMR Common Stock P - Purchase I 8,7500 228 571 2 000 1 943 423
2021-07-02 2021-06-30 4 Flynn James E Through Deerfield Private Design Fund III, L.P. LRMR Common Stock P - Purchase I 8,7500 228 569 2 000 1 943 406
2021-07-02 2021-06-30 4 Hamilton Thomas Edward LRMR Common Stock P - Purchase D 8,7500 56 710 496 190 130
2021-05-20 2021-05-12 4 Truitt Joseph LRMR Stock Option (right to buy) A - Award D 10,34 8 300 8 300
2021-05-17 2021-05-12 4 Hamilton Thomas Edward LRMR Stock Option (right to buy) A - Award D 10,34 8 300 8 300
2021-05-17 2021-05-12 4 Daniel Thomas O LRMR Stock Option (right to buy) A - Award D 10,34 8 300 8 300
2021-05-17 2021-05-12 4 THOMAS FRANK E LRMR Stock Option (right to buy) A - Award D 10,34 8 300 8 300
2021-05-17 2021-05-12 4 Barrett Peter LRMR Stock Option (right to buy) A - Award D 10,34 8 300 8 300
2021-05-17 2021-05-12 4 LEFF JONATHAN S LRMR Stock Option (right to buy) A - Award D 10,34 8 300 8 300
2021-05-17 2021-05-12 4 Flynn James E Through Deerfield Management Company, L.P. LRMR Stock Option (Right to Buy) A - Award I 10,34 8 300 8 300
2021-01-21 2021-01-19 4 BEN-MAIMON CAROLE LRMR Stock Option (Right to Buy) A - Award D 19,61 106 700 106 700
2021-01-21 2021-01-19 4 Celano Michael LRMR Stock Option (Right to Buy) A - Award D 19,61 42 000 42 000
2020-10-01 2020-09-29 4 Flynn James E Through Deerfield Management Company, L.P. LRMR Stock Option (Right to Buy) A - Award I 11,90 16 600 16 600
2020-09-30 2020-09-29 4 Hamilton Thomas Edward LRMR Stock Option (right to buy) A - Award D 11,90 16 600 16 600
2020-09-30 2020-09-29 4 Daniel Thomas O LRMR Stock Option (right to buy) A - Award D 11,90 16 600 16 600
2020-09-30 2020-09-29 4 Barrett Peter LRMR Stock Option (right to buy) A - Award D 11,90 16 600 16 600
2020-09-30 2020-09-29 4 Celano Michael LRMR Stock Option (right to buy) A - Award D 11,90 84 100 84 100
2020-09-30 2020-09-29 4 Truitt Joseph LRMR Stock Option (right to buy) A - Award D 11,90 16 600 16 600
2020-09-30 2020-09-29 4 LEFF JONATHAN S LRMR Stock Option (right to buy) A - Award D 11,90 16 600 16 600
2020-09-30 2020-09-29 4 THOMAS FRANK E LRMR Stock Option (right to buy) A - Award D 11,90 16 600 16 600
2020-09-30 2020-09-29 4 BEN-MAIMON CAROLE LRMR Stock Option (right to buy) A - Award D 11,90 411 400 411 400
2020-06-30 2020-06-26 4 BEN-MAIMON CAROLE LRMR Common Stock J - Other D 25 083 25 083
2020-06-30 2020-06-26 4 CHONDRIAL THERAPEUTICS HOLDINGS, LLC LRMR Common Stock J - Other D −6 091 242 8
2020-06-30 2020-06-26 4 Hamilton Thomas Edward FA Life Sciences, Inc. LRMR Common Stock J - Other I 159 433 292 853
2020-06-30 2020-06-26 4 Hamilton Thomas Edward LRMR Common Stock J - Other D 133 420 133 420
2020-06-08 3 Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC LRMR Common Stock I 12 182 500
2020-06-08 3 Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC LRMR Common Stock I 12 182 500
2020-06-08 3 Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC LRMR Common Stock I 12 182 500
2020-06-08 3 Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC LRMR Common Stock I 12 182 500
2020-06-08 3 Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC LRMR Common Stock I 12 182 500
2020-06-08 3 Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC LRMR Common Stock I 12 182 500
2020-06-08 3 Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC LRMR Common Stock I 12 182 500
2020-06-08 3 Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC LRMR Common Stock I 12 182 500
2020-06-08 3 Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC LRMR Common Stock I 12 182 500
2020-06-08 3 Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC LRMR Common Stock I 12 182 500
2020-06-05 2020-05-28 4 Celano Michael LRMR Stock Option (Right to Buy) A - Award D 11,88 60 479 60 479
2020-06-05 3 CHONDRIAL THERAPEUTICS HOLDINGS, LLC LRMR Common Stock D 12 182 500
2020-06-05 3 CHONDRIAL THERAPEUTICS HOLDINGS, LLC LRMR Common Stock D 12 182 500
2020-06-05 3 CHONDRIAL THERAPEUTICS HOLDINGS, LLC LRMR Common Stock D 12 182 500
2019-06-27 2019-06-26 4 PEREZ ROBERT J ZFGN Stock Option (Right to Buy) A - Award D 1,25 27 000 27 000
2019-06-27 2019-06-26 4 McDonough Cameron Geoffrey ZFGN Stock Option (Right to Buy) A - Award D 1,25 27 000 27 000
2019-06-27 2019-06-26 4 EVERETT WENDY ZFGN Stock Option (Right to Buy) A - Award D 1,25 27 000 27 000
2019-06-27 2019-06-26 4 LAMATTINA JOHN L ZFGN Stock Option (Right to Buy) A - Award D 1,25 27 000 27 000
2019-06-27 2019-06-26 4 Barrett Peter ZFGN Stock Option (Right to Buy) A - Award D 1,25 27 000 27 000
2019-06-27 2019-06-26 4 Daniel Thomas O ZFGN Stock Option (Right to Buy) A - Award D 1,25 27 000 27 000
2019-06-27 2019-06-26 4 THOMAS FRANK E ZFGN Stock Option (Right to Buy) A - Award D 1,25 27 000 27 000
2019-04-04 2019-04-02 4 Singhal Priya ZFGN Stock Option (Right to Buy) A - Award D 2,89 375 000 375 000
2019-01-28 2019-01-24 4 Barrett Peter ZFGN Stock Option (Right to Buy) A - Award D 4,38 21 396 21 396
2019-01-28 2019-01-24 4 McDonough Cameron Geoffrey ZFGN Stock Option (Right to Buy) A - Award D 4,38 11 804 11 804
2019-01-28 2019-01-24 4 Daniel Thomas O ZFGN Stock Option (Right to Buy) A - Award D 4,38 13 280 13 280
2019-01-28 2019-01-24 4 PEREZ ROBERT J ZFGN Stock Option (Right to Buy) A - Award D 4,38 5 717 5 717
2019-01-28 2019-01-24 4 PEREZ ROBERT J ZFGN Common Stock A - Award D 4,3800 4 423 19 5 322
2019-01-28 2019-01-24 4 LAMATTINA JOHN L ZFGN Common Stock A - Award D 4,3800 10 844 47 31 376
2019-01-24 2019-01-22 4 Allen Patricia L ZFGN Stock Option (Right to Buy) A - Award D 4,63 125 000 125 000
2019-01-24 2019-01-22 4 KIM DENNIS D ZFGN Stock Option (Right to Buy) A - Award D 4,63 95 000 95 000
2019-01-24 2019-01-22 4 Hatfield Jeffrey S. ZFGN Stock Option (Right to Buy) A - Award D 4,63 525 000 525 000
2019-01-24 2019-01-22 4 McVeigh Brian ZFGN Stock Option (Right to Buy) A - Award D 4,63 125 000 125 000
2018-07-02 2018-06-29 4 Atlas Venture Fund VII L P ZFGN Common Stock J - Other D −234 321 11
2018-07-02 2018-06-29 4 Atlas Venture Fund VII L P ZFGN Common Stock J - Other D −1 126 546 3 506 184
2018-06-29 2018-06-28 4 Hughes Thomas E. ZFGN Common Stock S - Sale D 10,0000 −32 000 −320 125 247
2018-06-07 2018-06-06 4 THOMAS FRANK E ZFGN Stock Option (Right to Buy) A - Award D 6,79 20 000 20 000
2018-06-07 2018-06-06 4 McDonough Cameron Geoffrey ZFGN Stock Option (Right to Buy) A - Award D 6,79 20 000 20 000
2018-06-07 2018-06-06 4 PEREZ ROBERT J ZFGN Stock Option (Right to Buy) A - Award D 6,79 20 000 20 000
2018-06-07 2018-06-06 4 Daniel Thomas O ZFGN Stock Option (Right to Buy) A - Award D 6,79 20 000 20 000
2018-06-07 2018-06-06 4 LAMATTINA JOHN L ZFGN Stock Option (Right to Buy) A - Award D 6,79 20 000 20 000
2018-06-07 2018-06-06 4 Barrett Peter ZFGN Stock Option (Right to Buy) A - Award D 6,79 20 000 20 000
2018-06-07 2018-06-06 4 EVERETT WENDY ZFGN Stock Option (Right to Buy) A - Award D 6,79 40 000 40 000
2018-06-07 2018-06-06 4 EVERETT WENDY ZFGN Stock Option (Right to Buy) A - Award D 6,79 20 000 20 000
2018-05-30 2018-05-29 4 McVeigh Brian ZFGN Stock Option (Right to Buy) A - Award D 6,46 225 000 225 000
2018-03-09 2018-03-07 4 Hughes Thomas E. ZFGN Common Stock S - Sale D 10,0000 −5 000 −50 157 247
2018-02-23 2018-02-22 4 Allen Patricia L ZFGN Stock Option (Right to Buy) A - Award D 7,77 125 000 125 000
2018-02-23 2018-02-22 4 Hatfield Jeffrey S. ZFGN Stock Option (Right to Buy) A - Award D 7,77 275 000 275 000
2018-02-23 2018-02-22 4 Hughes Thomas E. ZFGN Stock Option (right to buy) A - Award D 7,77 275 000 275 000
2018-02-23 2018-02-22 4 KIM DENNIS D ZFGN Stock Option (Right to Buy) A - Award D 7,77 125 000 125 000
2018-01-05 2018-01-03 4 PEREZ ROBERT J ZFGN Stock Option (Right to Buy) A - Award D 5,18 9 421 9 421
2018-01-05 2018-01-03 4 McDonough Cameron Geoffrey ZFGN Stock Option (Right to Buy) A - Award D 5,18 9 725 9 725
2018-01-05 2018-01-03 4 Booth Bruce ZFGN Stock Option (Right to Buy) A - Award D 5,18 8 509 8 509
2018-01-05 2018-01-03 4 Barrett Peter ZFGN Stock Option (Right to Buy) A - Award D 5,18 17 627 17 627
2018-01-05 2018-01-03 4 LAMATTINA JOHN L ZFGN Common Stock A - Award D 5,1800 9 169 47 20 532
2018-01-05 2018-01-03 4 Daniel Thomas O ZFGN Common Stock A - Award D 5,1800 8 687 45 19 452
2017-12-29 2017-12-29 4 Hatfield Jeffrey S. ZFGN Stock Option (Right to Buy) A - Award D 3,40 1 100 000 1 100 000
2017-10-17 2017-10-13 4 Heller Frances K ZFGN Common Stock P - Purchase D 3,8988 10 000 39 47 961
2017-10-11 2017-10-09 4 Hughes Thomas E. ZFGN Employee Stock Option (right to buy) A - Award D 3,40 275 000 275 000
2017-10-11 2017-10-09 4 Hatfield Jeffrey S. ZFGN Stock Option (Right to Buy) A - Award D 3,40 550 000 550 000
2017-07-12 2017-07-11 4 KIM DENNIS D ZFGN Common Stock P - Purchase D 3,3900 10 000 34 21 443
2017-06-23 2017-06-21 4 McDonough Cameron Geoffrey ZFGN Stock Option (Right to Buy) A - Award D 3,95 14 500 14 500
2017-06-23 2017-06-21 4 Daniel Thomas O ZFGN Stock Option (Right to Buy) A - Award D 3,95 14 500 14 500
2017-06-23 2017-06-21 4 PEREZ ROBERT J ZFGN Stock Option (Right to Buy) A - Award D 3,95 14 500 14 500
2017-06-23 2017-06-21 4 Heller Frances K ZFGN Stock Option (Right to Buy) A - Award D 3,95 14 500 14 500
2017-06-23 2017-06-21 4 Barrett Peter ZFGN Stock Option (Right to Buy) A - Award D 3,95 14 500 14 500
2017-06-23 2017-06-21 4 THOMAS FRANK E ZFGN Stock Option (Right to Buy) A - Award D 3,95 14 500 14 500
2017-06-23 2017-06-21 4 LAMATTINA JOHN L ZFGN Stock Option (Right to Buy) A - Award D 3,95 14 500 14 500
2017-06-23 2017-06-21 4 Booth Bruce ZFGN Stock Option (Right to Buy) A - Award D 3,95 14 500 14 500
2017-05-15 2017-05-11 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) M - Exercise D 0,82 −68 073 0
2017-05-15 2017-05-11 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) M - Exercise D 0,75 −6 210 0
2017-05-15 2017-05-11 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy M - Exercise D 0,75 −18 928 0
2017-05-15 2017-05-11 4 Hughes Thomas E. ZFGN Common Stock M - Exercise D 0,8200 68 073 56 157 371
2017-05-15 2017-05-11 4 Hughes Thomas E. ZFGN Common Stock M - Exercise D 0,7500 6 210 5 89 298
2017-05-15 2017-05-11 4 Hughes Thomas E. ZFGN Common Stock M - Exercise D 0,7500 18 928 14 83 088
2017-05-11 2017-05-11 4 KIM DENNIS D ZFGN Common Stock P - Purchase D 4,4000 9 800 43 11 443
2017-05-11 2017-05-10 4 KIM DENNIS D ZFGN Common Stock P - Purchase D 4,4000 200 1 1 643
2017-02-14 2017-02-13 4 Booth Bruce ZFGN Stock Option (Right to Buy) A - Award D 4,18 12 003 12 003
2017-02-14 2017-02-13 4 McDonough Cameron Geoffrey ZFGN Stock Option (Right to Buy) A - Award D 4,18 13 718 13 718
2017-02-14 2017-02-13 4 Daniel Thomas O ZFGN Common Stock A - Award D 4,1800 10 765 45 10 765
2017-02-14 2017-02-13 4 PEREZ ROBERT J ZFGN Stock Option (Right to Buy) A - Award D 4,18 13 289 13 289
2017-02-14 2017-02-13 4 LAMATTINA JOHN L ZFGN Common Stock A - Award D 4,1800 11 363 47 11 363
2017-02-14 2017-02-13 4 Barrett Peter ZFGN Stock Option (Right to Buy) A - Award D 4,18 24 864 24 864
2017-01-31 2017-01-27 4 Allen Patricia L ZFGN Stock Option (Right to Buy) A - Award D 4,05 88 000 88 000
2017-01-31 2017-01-27 4 KIM DENNIS D ZFGN Stock Option (Right to Buy) A - Award D 4,05 88 000 88 000
2017-01-31 2017-01-27 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) A - Award D 4,05 319 000 319 000
2016-12-20 2016-12-19 4 Heller Frances K ZFGN Common Stock P - Purchase D 3,2290 10 000 32 30 000
2016-11-17 2016-11-15 4 Heller Frances K ZFGN Common Stock P - Purchase D 3,5434 10 000 35 20 000
2016-08-31 2016-08-29 4 Hughes Thomas E. ZFGN Common Stock P - Purchase D 2,9987 10 000 30 63 936
2016-08-01 2016-07-20 4 Flynn James E Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock S - Sale I 3,3118 −901 430 −2 985 1 151 802
2016-08-01 2016-07-20 4 Flynn James E Through Deerfield International Master Fund, L.P. ZFGN Common Stock S - Sale I 3,3118 −246 439 −816 314 889
2016-08-01 2016-07-20 4 Flynn James E Through Deerfield Partners, L.P. ZFGN Common Stock S - Sale I 3,3118 −193 630 −641 247 413
2016-07-26 2016-07-26 4 Allen Patricia L ZFGN Common Stock P - Purchase D 3,1500 8 200 26 19 793
2016-07-26 2016-07-25 4 Allen Patricia L ZFGN Common Stock P - Purchase D 3,0810 7 800 24 11 593
2016-07-26 2016-07-22 4 Heller Frances K ZFGN Common Stock P - Purchase D 2,9900 10 000 30 10 000
2016-07-26 2016-07-22 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) M - Exercise D 0,75 25 000 18 928
2016-07-26 2016-07-22 4 Hughes Thomas E. ZFGN Common Stock P - Purchase D 3,0208 5 000 15 53 936
2016-07-26 2016-07-22 4 Hughes Thomas E. ZFGN Common Stock M - Exercise D 0,7500 25 000 19 48 936
2016-07-01 2016-06-30 4 THOMAS FRANK E ZFGN Stock Option (Right to Buy) A - Award D 5,99 12 000 12 000
2016-07-01 2016-06-30 4 PEREZ ROBERT J ZFGN Stock Option (Right to Buy) A - Award D 5,99 12 000 12 000
2016-07-01 2016-06-30 4 Barrett Peter ZFGN Stock Option (Right to Buy) A - Award D 5,99 12 000 12 000
2016-07-01 2016-06-30 4 LAMATTINA JOHN L ZFGN Stock Option (Right to Buy) A - Award D 5,99 12 000 12 000
2016-07-01 2016-06-30 4 Heller Frances K ZFGN Stock Option (Right to Buy) A - Award D 5,99 12 000 12 000
2016-07-01 2016-06-30 4 Booth Bruce ZFGN Stock Option (Right to Buy) A - Award D 5,99 12 000 12 000
2016-07-01 2016-06-30 4 Daniel Thomas O ZFGN Stock Option (Right to Buy) A - Award D 5,99 12 000 12 000
2016-07-01 2016-06-30 4 McDonough Cameron Geoffrey ZFGN Stock Option (Right to Buy) A - Award D 5,99 12 000 12 000
2016-04-12 2016-01-07 4 PEREZ ROBERT J See note ZFGN Common Stock A - Award I 6,2900 5 564 35 5 564
2016-04-04 2016-03-31 4 Allen Patricia L ZFGN Stock Option (Right to Buy) A - Award D 6,68 36 000 36 000
2016-04-04 2016-03-31 4 Allen Patricia L ZFGN Stock Option (Right to Buy) A - Award D 6,68 72 000 72 000
2016-04-04 2016-03-31 4 KIM DENNIS D ZFGN Stock Option (Right to Buy) A - Award D 6,68 37 500 37 500
2016-04-04 2016-03-31 4 KIM DENNIS D ZFGN Stock Option (Right to Buy) A - Award D 6,68 75 000 75 000
2016-04-04 2016-04-01 4 Daniel Thomas O ZFGN Stock Option (Right to Buy) A - Award D 6,70 3 841 3 841
2016-04-04 2016-04-01 4 Daniel Thomas O ZFGN Stock Option (Right to Buy) A - Award D 6,70 24 000 24 000
2016-04-04 2016-04-01 4 McDonough Cameron Geoffrey ZFGN Stock Option (Right to Buy) A - Award D 7,91 6 100 6 100
2016-04-04 2016-04-01 4 McDonough Cameron Geoffrey ZFGN Common Stock D - Sale to Issuer D 7,9100 −4 424 −35 0
2016-04-04 2016-03-31 4 Secor Alicia ZFGN Stock Option (Right to Buy) A - Award D 6,68 −26 500 26 500
2016-04-04 2016-03-31 4 Secor Alicia ZFGN Stock Option (Right to Buy) A - Award D 6,68 −53 000 53 000
2016-04-04 2016-03-31 4 Loustau Patrick ZFGN Stock Option (Right to Buy) A - Award D 6,68 56 500 56 500
2016-04-04 2016-03-31 4 Loustau Patrick ZFGN Stock Option (Right to Buy) A - Award D 6,68 113 000 113 000
2016-04-04 2016-03-31 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) A - Award D 6,68 124 500 124 500
2016-04-04 2016-03-31 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) A - Award D 6,68 249 000 249 000
2016-02-17 2016-02-12 4 Flynn James E Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock P - Purchase I 6,2466 13 872 87 2 053 232
2016-02-17 2016-02-12 4 Flynn James E Through Deerfield International Master Fund, L.P. ZFGN Common Stock P - Purchase I 6,2466 28 377 177 561 328
2016-02-17 2016-02-12 4 Flynn James E Through Deerfield Partners, L.P. ZFGN Common Stock P - Purchase I 6,2466 22 296 139 441 043
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock I 4 705 436
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P. ZFGN Common Stock I 3 049 910
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock I 4 705 436
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P. ZFGN Common Stock I 3 138 914
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P. ZFGN Common Stock I 3 049 910
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock I 4 705 436
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P. ZFGN Common Stock I 3 138 914
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P. ZFGN Common Stock I 3 138 914
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock I 4 705 436
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P. ZFGN Common Stock I 3 049 910
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P. ZFGN Common Stock I 3 049 910
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock I 4 705 436
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P. ZFGN Common Stock I 3 049 910
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P. ZFGN Common Stock I 3 138 914
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock I 4 705 436
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P. ZFGN Common Stock I 3 049 910
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P. ZFGN Common Stock I 3 138 914
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock I 4 705 436
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P. ZFGN Common Stock I 3 049 910
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P. ZFGN Common Stock I 3 138 914
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P. ZFGN Common Stock I 3 138 914
2016-02-11 2016-02-11 4 Flynn James E Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock P - Purchase I 6,1884 504 3 2 039 360
2016-02-11 2016-02-11 4 Flynn James E Through Deerfield International Master Fund, L.P. ZFGN Common Stock P - Purchase I 6,1884 1 030 6 532 951
2016-02-11 2016-02-11 4 Flynn James E Through Deerfield Partners, L.P. ZFGN Common Stock P - Purchase I 6,1884 810 5 418 747
2016-02-11 2016-02-10 4 Flynn James E Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock P - Purchase I 6,2323 32 501 203 2 038 856
2016-02-11 2016-02-10 4 Flynn James E Through Deerfield International Master Fund, L.P. ZFGN Common Stock P - Purchase I 6,2323 66 486 414 531 921
2016-02-11 2016-02-10 4 Flynn James E Through Deerfield Partners, L.P. ZFGN Common Stock P - Purchase I 6,2323 52 239 326 417 937
2016-02-11 2016-02-09 4 Flynn James E Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock P - Purchase I 5,7291 24 484 140 2 006 355
2016-02-11 2016-02-09 4 Flynn James E Through Deerfield International Master Fund, L.P. ZFGN Common Stock P - Purchase I 5,7291 50 086 287 465 435
2016-02-11 2016-02-09 4 Flynn James E Through Deerfield Partners, L.P. ZFGN Common Stock P - Purchase I 5,7291 39 353 225 365 698
2016-01-27 2016-01-25 4 Barrett Peter ZFGN Common Stock A - Award D 7,9100 8 849 70 4 643 327
2016-01-27 2016-01-25 4 McDonough Cameron Geoffrey ZFGN Common Stock A - Award D 7,9100 4 424 35 4 424
2016-01-27 2016-01-25 4 Booth Bruce ZFGN Common Stock A - Award D 7,9100 4 424 35 4 638 028
2016-01-27 2016-01-25 4 LAMATTINA JOHN L ZFGN Stock Option (Right to Buy) A - Award D 7,91 9 150 9 150
2016-01-08 2016-01-08 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) M - Exercise D 0,75 −10 000 43 928
2016-01-08 2016-01-08 4 Hughes Thomas E. ZFGN Common Stock M - Exercise D 0,7500 10 000 8 21 320
2015-10-30 2015-10-28 4 PEREZ ROBERT J ZFGN Common Stock A - Award D 10,4500 899 9 899
2015-10-30 2015-10-28 4 McDonough Cameron Geoffrey ZFGN Stock Option (Right to Buy) A - Award D 10,45 1 207 1 207
2015-10-20 2015-09-14 4/A KIM DENNIS D ZFGN Common Stock S - Sale D 40,0000 −593 −24 0
2015-10-20 2015-09-17 4/A KIM DENNIS D ZFGN Common Stock S - Sale D 40,0000 −9 142 −366 0
2015-10-20 2015-09-15 4/A KIM DENNIS D ZFGN Common Stock S - Sale D 40,0000 −30 265 −1 211 0
2015-09-28 2015-09-24 4 McDonough Cameron Geoffrey ZFGN Stock Option (Right to Buy) A - Award D 40,56 24 000 24 000
2015-09-28 2015-09-24 4 PEREZ ROBERT J ZFGN Stock Option (Right to Buy) A - Award D 40,56 24 000 24 000
2015-09-25 2015-09-24 4 STARR KEVIN P ZFGN Common Stock J - Other D 98 834 370 323
2015-09-25 2015-09-24 4 STARR KEVIN P ZFGN Common Stock J - Other I −476 170 0
2015-09-25 2015-09-24 4 STARR KEVIN P ZFGN Common Stock J - Other I 476 170 476 170
2015-09-25 2015-09-24 4 STARR KEVIN P ZFGN Common Stock S - Sale I 44,1000 −61 630 −2 718 210 371
2015-09-25 2015-09-24 4 STARR KEVIN P ZFGN Common Stock S - Sale I 43,7300 −74 949 −3 278 272 001
2015-09-25 2015-09-24 4 STARR KEVIN P ZFGN Common Stock J - Other I −1 655 095 346 950
2015-09-24 2015-09-23 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) M - Exercise D 0,75 −10 500 53 928
2015-09-24 2015-09-23 4 Hughes Thomas E. ZFGN Common Stock M - Exercise D 0,7500 10 500 8 11 320
2015-09-21 2015-09-18 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) M - Exercise D 2,45 −23 126 160 555
2015-09-21 2015-09-18 4 Hughes Thomas E. ZFGN Common Stock S - Sale D 45,0000 −23 126 −1 041 820
2015-09-21 2015-09-18 4 Hughes Thomas E. ZFGN Common Stock M - Exercise D 2,4500 23 126 57 23 946
2015-09-21 2015-09-17 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) M - Exercise D 2,45 −4 874 183 681
2015-09-21 2015-09-17 4 Hughes Thomas E. ZFGN Common Stock S - Sale D 40,0000 −22 500 −900 820
2015-09-21 2015-09-17 4 Hughes Thomas E. ZFGN Common Stock M - Exercise D 2,4500 4 874 12 23 320
2015-09-21 2015-09-18 4 Goldberg Avi Y. ZFGN Common Stock S - Sale D 45,0000 −5 000 −225 53 734
2015-09-21 2015-09-17 4 Secor Alicia ZFGN Stock Option (Right to Buy) M - Exercise D 9,67 −25 000 134 235
2015-09-21 2015-09-17 4 Secor Alicia ZFGN Common Stock S - Sale D 41,0500 −1 256 −52 0
2015-09-21 2015-09-17 4 Secor Alicia ZFGN Common Stock S - Sale D 41,0500 −25 000 −1 026 1 256
2015-09-21 2015-09-17 4 Secor Alicia ZFGN Common Stock M - Exercise D 9,6700 25 000 242 26 256
2015-09-17 2015-09-17 4 KIM DENNIS D ZFGN Stock Option (Right to Buy) M - Exercise D 1,57 −9 142 103 312
2015-09-17 2015-09-17 4 KIM DENNIS D ZFGN Common Stock S - Sale D 40,0000 −9 142 −366 0
2015-09-17 2015-09-17 4 KIM DENNIS D ZFGN Common Stock M - Exercise D 1,5700 9 142 14 9 142
2015-09-17 2015-09-15 4 KIM DENNIS D ZFGN Stock Option (Right to Buy) M - Exercise D 1,57 −30 265 112 454
2015-09-17 2015-09-15 4 KIM DENNIS D ZFGN Common Stock S - Sale D 40,0000 −30 265 −1 211 0
2015-09-17 2015-09-15 4 KIM DENNIS D ZFGN Common Stock M - Exercise D 1,5700 30 265 48 30 265
2015-09-16 2015-09-14 4 KIM DENNIS D ZFGN Stock Option (Right to Buy) M - Exercise D 1,57 −593 142 719
2015-09-16 2015-09-14 4 KIM DENNIS D ZFGN Common Stock S - Sale D 40,0000 −593 −24 0
2015-09-16 2015-09-14 4 KIM DENNIS D ZFGN Common Stock M - Exercise D 1,5700 593 1 593
2015-07-24 2015-07-23 4 STARR KEVIN P ZFGN Common Stock J - Other D 99 351 271 489
2015-07-24 2015-07-23 4 STARR KEVIN P ZFGN Common Stock J - Other I −479 081 0
2015-07-24 2015-07-23 4 STARR KEVIN P ZFGN Common Stock J - Other I 479 081 479 081
2015-07-24 2015-07-23 4 STARR KEVIN P ZFGN Common Stock J - Other I −1 200 000 2 002 045
2015-07-24 2015-07-23 4 THIRD ROCK VENTURES LP ZFGN Common Stock J - Other D −479 081 0
2015-07-24 2015-07-23 4 THIRD ROCK VENTURES LP ZFGN Common Stock J - Other D 479 081 479 081
2015-07-24 2015-07-23 4 THIRD ROCK VENTURES LP ZFGN Common Stock J - Other D −1 200 000 2 002 045
2015-07-15 2015-07-13 4 STARR KEVIN P ZFGN Stock Option (Right to Buy) A - Award D 37,15 12 000 12 000
2015-07-15 2015-07-13 4 Goldberg Avi Y. ZFGN Stock Option (Right to Buy) A - Award D 37,15 12 000 12 000
2015-07-15 2015-07-13 4 Barrett Peter ZFGN Stock Option (Right to Buy) A - Award D 37,15 12 000 12 000
2015-07-15 2015-07-13 4 THOMAS FRANK E ZFGN Stock Option (Right to Buy) A - Award D 37,15 12 000 12 000
2015-07-15 2015-07-13 4 LAMATTINA JOHN L ZFGN Stock Option (Right to Buy) A - Award D 37,15 12 000 12 000
2015-07-15 2015-07-13 4 Booth Bruce ZFGN Stock Option (Right to Buy) A - Award D 37,15 12 000 12 000
2015-07-15 2015-07-13 4 Heller Frances K ZFGN Stock Option (Right to Buy) A - Award D 37,15 12 000 12 000
2015-06-12 2015-06-10 4 Goldberg Avi Y. ZFGN Common Stock S - Sale D 35,0000 −3 000 −105 58 734
2015-06-03 2015-06-01 4 Goldberg Avi Y. ZFGN Common Stock S - Sale D 32,2262 −2 000 −64 61 734
2015-05-18 2015-05-15 4 STARR KEVIN P ZFGN Common Stock J - Other D 92 041 172 138
2015-05-18 2015-05-15 4 STARR KEVIN P ZFGN Common Stock J - Other I −443 935 0
2015-05-18 2015-05-15 4 STARR KEVIN P ZFGN Common Stock J - Other I 443 935 443 935
2015-05-18 2015-05-15 4 STARR KEVIN P ZFGN Common Stock J - Other I −1 000 000 3 202 045
2015-05-18 2015-05-15 4 THIRD ROCK VENTURES LP ZFGN Common Stock J - Other D −443 935 0
2015-05-18 2015-05-15 4 THIRD ROCK VENTURES LP ZFGN Common Stock J - Other D 443 935 443 935
2015-05-18 2015-05-15 4 THIRD ROCK VENTURES LP ZFGN Common Stock J - Other D −1 000 000 3 202 045
2015-03-26 2015-03-24 4 Atlas Venture Fund VII L P ZFGN Common Stock J - Other D −1 000 000 4 632 730
2015-03-25 2015-03-24 4 STARR KEVIN P ZFGN Common Stock J - Other D 71 989 80 097
2015-03-25 2015-03-24 4 STARR KEVIN P ZFGN Common Stock J - Other I −346 658 0
2015-03-25 2015-03-24 4 STARR KEVIN P ZFGN Common Stock J - Other I 346 658 346 658
2015-03-25 2015-03-24 4 STARR KEVIN P ZFGN Common Stock J - Other I −1 400 000 4 202 045
2015-03-25 2015-03-24 4 THIRD ROCK VENTURES LP ZFGN Common Stock J - Other D −346 658 0
2015-03-25 2015-03-24 4 THIRD ROCK VENTURES LP ZFGN Common Stock J - Other D 346 658 346 658
2015-03-25 2015-03-24 4 THIRD ROCK VENTURES LP ZFGN Common Stock J - Other D −1 400 000 4 202 045
2015-03-19 2015-03-17 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) A - Award D 45,57 180 000 180 000
2015-03-03 2015-02-27 4 Allen Patricia L ZFGN Stock Option (Right to Buy) A - Award D 38,65 60 000 187 388
2015-03-03 2015-02-27 4 KIM DENNIS D ZFGN Stock Option (Right to Buy) A - Award D 38,65 90 000 281 509
2015-03-03 2015-02-27 4 Secor Alicia ZFGN Stock Option (Right to Buy) A - Award D 38,65 60 000 219 235
2015-03-03 2015-02-27 4 Loustau Patrick ZFGN Stock Option (Right to Buy) A - Award D 38,65 45 000 324 777
2015-01-12 2015-01-08 4 Booth Bruce ZFGN Common Stock A - Award D 40,0400 874 35 5 633 604
2015-01-12 2015-01-08 4 STARR KEVIN P ZFGN Common Stock A - Award D 40,0400 1 248 50 9 356
2015-01-12 2015-01-08 4 Barrett Peter ZFGN Common Stock A - Award D 40,0400 1 748 70 5 634 478
2015-01-12 2015-01-08 4 LAMATTINA JOHN L ZFGN Stock Option (Right to Buy) A - Award D 40,04 1 593 9 554
2014-11-03 2014-10-30 4 Heller Frances K ZFGN Stock Option (Right to Buy) A - Award D 21,34 13 327 13 327
2014-06-26 2014-06-24 4 THOMAS FRANK E ZFGN Stock Option (Right to Buy) A - Award D 16,00 13 327 13 327
2014-06-26 2014-06-24 4 STARR KEVIN P ZFGN Series D Preferred Stock C - Conversion I −4 666 478 0
2014-06-26 2014-06-24 4 STARR KEVIN P ZFGN Series C Preferred Stock C - Conversion I −8 263 595 0
2014-06-26 2014-06-24 4 STARR KEVIN P ZFGN Series B Preferred Stock C - Conversion I −22 250 770 0
2014-06-26 2014-06-24 4 STARR KEVIN P ZFGN Common Stock C - Conversion I 743 070 5 610 153
2014-06-26 2014-06-24 4 STARR KEVIN P ZFGN Common Stock C - Conversion I 1 315 859 4 867 083
2014-06-26 2014-06-24 4 STARR KEVIN P ZFGN Common Stock C - Conversion I 3 543 116 3 551 224
2014-06-26 2014-06-24 4 Barrett Peter ZFGN Series D Preferred Stock C - Conversion I −4 690 696 0
2014-06-26 2014-06-24 4 Barrett Peter ZFGN Series C Preferred Stock C - Conversion I −8 263 595 0
2014-06-26 2014-06-24 4 Barrett Peter ZFGN Series B Preferred Stock C - Conversion I −17 651 253 0
2014-06-26 2014-06-24 4 Barrett Peter ZFGN Series A Preferred Stock C - Conversion I −4 768 001 0
2014-06-26 2014-06-24 4 Barrett Peter ZFGN Common Stock C - Conversion I 746 926 5 632 730
2014-06-26 2014-06-24 4 Barrett Peter ZFGN Common Stock C - Conversion I 1 315 859 4 885 804
2014-06-26 2014-06-24 4 Barrett Peter ZFGN Common Stock C - Conversion I 2 810 709 3 569 945
2014-06-26 2014-06-24 4 Barrett Peter ZFGN Common Stock C - Conversion I 759 236 759 236
2014-06-26 2014-06-24 4 Atlas Venture Fund VII L P ZFGN Series D Preferred Stock C - Conversion D −4 690 696 0
2014-06-26 2014-06-24 4 Atlas Venture Fund VII L P ZFGN Series C Preferred Stock C - Conversion D −8 263 595 0
2014-06-26 2014-06-24 4 Atlas Venture Fund VII L P ZFGN Series B Preferred Stock C - Conversion D −17 651 253 0
2014-06-26 2014-06-24 4 Atlas Venture Fund VII L P ZFGN Series A Preferred Stock C - Conversion D −4 768 001 0
2014-06-26 2014-06-24 4 Atlas Venture Fund VII L P ZFGN Common Stock C - Conversion D 746 926 5 632 730
2014-06-26 2014-06-24 4 Atlas Venture Fund VII L P ZFGN Common Stock C - Conversion D 1 315 859 4 885 804
2014-06-26 2014-06-24 4 Atlas Venture Fund VII L P ZFGN Common Stock C - Conversion D 2 810 709 3 569 945
2014-06-26 2014-06-24 4 Atlas Venture Fund VII L P ZFGN Common Stock C - Conversion D 759 236 759 236
2014-06-26 2014-06-24 4 Booth Bruce ZFGN Series D Preferred Stock C - Conversion I −4 690 696 0
2014-06-26 2014-06-24 4 Booth Bruce ZFGN Series C Preferred Stock C - Conversion I −8 263 595 0
2014-06-26 2014-06-24 4 Booth Bruce ZFGN Series B Preferred Stock C - Conversion I −17 651 253 0
2014-06-26 2014-06-24 4 Booth Bruce ZFGN Series A Preferred Stock C - Conversion I −4 768 001 0
2014-06-26 2014-06-24 4 Booth Bruce ZFGN Common Stock C - Conversion I 746 926 5 632 730
2014-06-26 2014-06-24 4 Booth Bruce ZFGN Common Stock C - Conversion I 1 315 859 4 885 804
2014-06-26 2014-06-24 4 Booth Bruce ZFGN Common Stock C - Conversion I 2 810 709 3 569 945
2014-06-26 2014-06-24 4 Booth Bruce ZFGN Common Stock C - Conversion I 759 236 759 236
2014-06-26 2014-06-24 4 THIRD ROCK VENTURES LP ZFGN Series D Preferred Stock C - Conversion D −4 666 478 0
2014-06-26 2014-06-24 4 THIRD ROCK VENTURES LP ZFGN Series C Preferred Stock C - Conversion D −8 263 595 0
2014-06-26 2014-06-24 4 THIRD ROCK VENTURES LP ZFGN Series B Preferred Stock C - Conversion D −22 250 770 0
2014-06-26 2014-06-24 4 THIRD ROCK VENTURES LP ZFGN Common Stock C - Conversion D 743 070 5 602 045
2014-06-26 2014-06-24 4 THIRD ROCK VENTURES LP ZFGN Common Stock C - Conversion D 1 315 859 4 858 975
2014-06-26 2014-06-24 4 THIRD ROCK VENTURES LP ZFGN Common Stock C - Conversion D 3 543 116 3 543 116
2014-06-26 2014-06-24 4 Loustau Patrick ZFGN Stock Option (Right to Buy) A - Award D 16,00 279 777 279 777
2014-06-23 2014-06-19 4 Secor Alicia Held by Spouse ZFGN Common Stock P - Purchase I 20,0000 4 000 80 4 000
2014-06-18 3 STARR KEVIN P ZFGN Common Stock D 16 216
2014-06-18 3 STARR KEVIN P ZFGN Common Stock D 16 216
2014-06-18 3 Hughes Thomas E. ZFGN Common Stock D 70 506
2014-06-18 3 Hughes Thomas E. ZFGN Common Stock D 70 506
2014-06-18 3 Goldberg Avi Y. ZFGN Common Stock I 695 284
2014-06-18 3 Goldberg Avi Y. ZFGN Common Stock I 695 284
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
Other Listings
DE:ZA71 3,58 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista